Deer Placenta Cosmetics
[INQ. NO. 2211C42] Deer placenta has a homing effect by finding and treating problem areas on its own. It is also rich in ingredients including growth factors, immunity strengthening nutrients, amino acids, and various vitamins.
In particular, various growth factors such as FGF and EGF are activated to proliferate stem cells in the body, helping to prevent aging, improve immunity, relieve inflammation, prevent adult diseases, and promote skin health.
D.PL Cell Infusion Program is made using Deerplexo, a raw material mixed with placenta and antler of New Zealand deer, Lakei-Exo (lactobacillus + patented technology), 13Mega-Peptide, and collagen water instead of purified water as main ingredients.
In addition, it has two technical patents: a method for separating exosomes in high yield from a cell culture medium, an elastic liposome composition, and a cosmetic composition comprising the same; a patented formulation for a nanogel type emulsion with a cell membrane-like structure using the self-association gel property and a cosmetic composition using the same was applied to the product.
D.PL Edition, containing clean New Zealand deer placenta is produced by UB Bio, established in New Zealand in 1980, applying a state-of-the-art method that minimizes nutrient loss in deer placenta through freeze drying.
It is manufactured using patented bioactive technology to increase absorption in the human body by more than 80%.
The core ingredients of D.PL Edition are hydrolyzate of New Zealand deers’ placenta, Emodin (mycelium cultured herbal extract from reishi mushroom), and short-chain fatty acids.
Emodin and short-chain fatty acids are core patented technologies of the Central Microbial Research Institute, and the substance called ‘Emodine’ was studied twice in 2016 and 2020 through an R&D support project of the Ministry of Agriculture, Food and Rural Affairs. As a result, it established a mechanism using emodin extracted from natural aloe and Hojang root, and patents have been obtained for efficacy evaluation and manufacturing methods.
When emodin was administered simultaneously to a targeted anticancer agent, it resulted in an increase in cancer cell death, a decrease in the target molecule protein in the tumor tissue, a decrease in the cassia-induced PTHLH in the blood, and the inhibition of COVID-19 through various researches. It was also registered in science-specific databases including Science Direct and Antivirus Research.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods
